Aclarion Net Income Over Time
| ACON Stock | USD 2.75 0.39 16.53% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Aclarion Performance and Aclarion Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Aclarion diversify its offerings? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aclarion data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.12) | Revenue Per Share | Quarterly Revenue Growth 0.761 | Return On Assets | Return On Equity |
Investors evaluate Aclarion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Aclarion's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Aclarion's market price to deviate significantly from intrinsic value.
Understanding that Aclarion's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aclarion represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Aclarion's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Aclarion and related stocks such as MSP Recovery, Bullfrog AI Holdings, and Kazia Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MSPR | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (33.1 M) | (7.4 M) | (56.3 M) | (360.5 M) | (324.4 M) | (308.2 M) |
| BFRG | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (585.8 K) | (2.8 M) | (5.4 M) | (7 M) | (6.3 M) | (6 M) |
| KZIA | (17.1 M) | 1.3 M | (1 M) | (7.5 M) | (7.1 M) | (12.1 M) | (10.7 M) | (6 M) | (10.3 M) | (12.5 M) | (8.4 M) | (25 M) | (20.5 M) | (26.8 M) | (20.7 M) | (23.8 M) | (25 M) |
| SNGX | (1.2 M) | (2.4 M) | (4.2 M) | (10.1 M) | (6.7 M) | (7.8 M) | (3.2 M) | (7.1 M) | (8.9 M) | (9.4 M) | (17.7 M) | (12.6 M) | (13.8 M) | (6.1 M) | (8.3 M) | (7.4 M) | (7.8 M) |
| CANF | (3.7 M) | (6.7 M) | (5.6 M) | (8.3 M) | (6.1 M) | (4.8 M) | (6.9 M) | (5 M) | (6.6 M) | (12.6 M) | (14.4 M) | (12.6 M) | (10.2 M) | (7.6 M) | (7.9 M) | (7.1 M) | (7.4 M) |
| CMND | (33.2 K) | (33.2 K) | (33.2 K) | (33.2 K) | (46.9 K) | (24.2 K) | (6.5 K) | (194.5 K) | (105.3 K) | (233.2 K) | (3.7 M) | (9.9 M) | (11.9 M) | (7.3 M) | (5.4 M) | (4.9 M) | (5.1 M) |
| BNBX | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (8.3 M) | (9.9 M) | (7 M) | (15.2 M) | (13.6 M) | (14.3 M) |
| ENSC | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | 2.1 M | 1.5 M | 56.8 K | (29.1 M) | (25 M) | (10.6 M) | (8 M) | (7.2 M) | (7.5 M) |
Aclarion and related stocks such as MSP Recovery, Bullfrog AI Holdings, and Kazia Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Aclarion financial statement analysis. It represents the amount of money remaining after all of Aclarion operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Aclarion | ACON |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 8181 Arista Place, |
| Exchange | NASDAQ Exchange |
USD 2.75
Check out Aclarion Performance and Aclarion Correlation. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Aclarion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.